DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DNA-immunisation with dengue virus E protein domains I/II, but not domain III, enhances Zika, West Nile and Yellow Fever virus infection
Authors
Keywords
Antibodies, West Nile virus, Enzyme-linked immunoassays, Flaviviruses, Antibody response, Vaccines, Dengue virus, Immune response
Journal
PLoS One
Volume 12, Issue 7, Pages e0181734
Publisher
Public Library of Science (PLoS)
Online
2017-07-26
DOI
10.1371/journal.pone.0181734
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination
- (2017) Norbert Pardi et al. NATURE
- Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity
- (2017) Susana V. Bardina et al. SCIENCE
- IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity
- (2017) Taia T. Wang et al. SCIENCE
- Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope
- (2017) Alexander Rouvinski et al. Nature Communications
- Temperature-dependent folding allows stable dimerization of secretory and virus-associated E proteins of Dengue and Zika viruses in mammalian cells
- (2017) J. L. Slon Campos et al. Scientific Reports
- Structural Basis of Zika Virus-Specific Antibody Protection
- (2016) Haiyan Zhao et al. CELL
- Zika Virus
- (2016) Didier Musso et al. CLINICAL MICROBIOLOGY REVIEWS
- Structural basis of potent Zika–dengue virus antibody cross-neutralization
- (2016) Giovanna Barba-Spaeth et al. NATURE
- Vaccine protection against Zika virus from Brazil
- (2016) Rafael A. Larocca et al. NATURE
- Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus
- (2016) Wanwisa Dejnirattisai et al. NATURE IMMUNOLOGY
- Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus
- (2016) Lalita Priyamvada et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rapid development of a DNA vaccine for Zika virus
- (2016) K. A. Dowd et al. SCIENCE
- Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys
- (2016) P. Abbink et al. SCIENCE
- The 3.8 A resolution cryo-EM structure of Zika virus
- (2016) D. Sirohi et al. SCIENCE
- Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection
- (2016) K. Stettler et al. SCIENCE
- Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus
- (2016) J. A. Swanstrom et al. mBio
- Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice
- (2016) Chen-Yi Chiang et al. Scientific Reports
- Cross-reactive antibodies enhance live attenuated virus infection for increased immunogenicity
- (2016) Kuan Rong Chan et al. Nature Microbiology
- Preventative Vaccines for Zika Virus Outbreak: Preliminary Evaluation
- (2016) Eun Kim et al. EBioMedicine
- Secretion of dengue virus envelope protein ectodomain from mammalian cells is dependent on domain II serotype and affects the immune response upon DNA vaccination
- (2015) J. L. Slon Campos et al. JOURNAL OF GENERAL VIROLOGY
- Recognition determinants of broadly neutralizing human antibodies against dengue viruses
- (2015) Alexander Rouvinski et al. NATURE
- Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
- (2015) Sri Rezeki Hadinegoro et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
- (2015) Luis Villar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nucleic acid (DNA) immunization as a platform for dengue vaccine development
- (2015) Kevin R. Porter et al. VACCINE
- Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes
- (2015) Monica Poggianella et al. PLoS Neglected Tropical Diseases
- The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response
- (2015) Jacky Flipse et al. PLoS Neglected Tropical Diseases
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
- (2014) Wanwisa Dejnirattisai et al. NATURE IMMUNOLOGY
- Dengue Viruses Are Enhanced by Distinct Populations of Serotype Cross-Reactive Antibodies in Human Immune Sera
- (2014) Ruklanthi de Alwis et al. PLoS Pathogens
- Mouse Models to Study Dengue Virus Immunology and Pathogenesis
- (2014) Raphaël M. Zellweger et al. Frontiers in Immunology
- Functional Analysis of Antibodies against Dengue Virus Type 4 Reveals Strain-Dependent Epitope Exposure That Impacts Neutralization and Protection
- (2013) S. Sukupolvi-Petty et al. JOURNAL OF VIROLOGY
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- Dengue Virus Neutralization in Cells Expressing Fc Gamma Receptors
- (2013) Tanu Chawla et al. PLoS One
- Correlation between Dengue-Specific Neutralizing Antibodies and Serum Avidity in Primary and Secondary Dengue Virus 3 Natural Infections in Humans
- (2013) Andreas Puschnik et al. PLoS Neglected Tropical Diseases
- Dissection of Antibody Specificities Induced by Yellow Fever Vaccination
- (2013) Oksana Vratskikh et al. PLoS Pathogens
- Mechanistic Study of Broadly Neutralizing Human Monoclonal Antibodies against Dengue Virus That Target the Fusion Loop
- (2012) J. M. Costin et al. JOURNAL OF VIROLOGY
- Dengue
- (2012) Cameron P. Simmons et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
- (2012) R. de Alwis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Animal Models of Dengue Virus Infection
- (2012) Simona Zompi et al. Viruses-Basel
- Antibody-mediated neutralization of flaviviruses: A reductionist view
- (2011) Kimberly A. Dowd et al. VIROLOGY
- The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
- (2010) Martina Beltramello et al. Cell Host & Microbe
- A minimal peptide substrate in biotin holoenzyme synthetase-catalyzed biotinylation
- (2010) Dorothy Beckett et al. PROTEIN SCIENCE
- Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
- (2010) W. Dejnirattisai et al. SCIENCE
- Report of an NIAID workshop on dengue animal models
- (2010) M. Cristina Cassetti et al. VACCINE
- A tetravalent recombinant dengue domain III protein vaccine stimulates neutralizing and enhancing antibodies in mice
- (2010) Olivia K.T. Block et al. VACCINE
- The Complexity of Antibody-Dependent Enhancement of Dengue Virus Infection
- (2010) Maria G. Guzman et al. Viruses-Basel
- Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody
- (2009) W.M.P.B. Wahala et al. VIROLOGY
- In vivo site-specific biotinylation of proteins within the secretory pathway using a single vector system
- (2008) Andrea Predonzani et al. BMC BIOTECHNOLOGY
- Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 Virus
- (2008) G. D. Gromowski et al. JOURNAL OF VIROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started